优抵生物(UltraDx Bio)成立于2022年,致力于将*的Simoa单分子数字化免疫检测技术引入中国临床实践,聚焦阿尔茨海默病等神经退行性疾病的早期筛查与诊断。核心产品UD-X全自动单分子荧光免疫分析仪及磷酸化Tau-217蛋白检测试剂盒已获得国家药品监督管理局注册证。公司与复旦大学附属华山医院等临床机构开展合作研究,并参与国家科技重大专项项目。公司在上海和石家庄设有研发与生产中心。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows